| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |